Explore Products
Tumor Cell Lines

COV362

  • 297
A human ovarian epithelial-endometroid carcinoma cell line established from a pleural effusion. Anchorage-independent growth in agar has been reported. The cell line COV362.4 is a subclone of this cell line.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Product Code

Cov362; COV-362

Species

Human

Cat.No

ABC-TC5589

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Ovary

Disease

Ovarian Epithelial Endometroid Cancer

Storage

Liquid Nitrogen

Product Type

Human Ovarian Cancer Cell Lines

Description

Cov362
COV362 is a human ovarian epithelial-endometrioid carcinoma cell line that was originally isolated from the pleural effusion of an age-unspecified female patient with high-grade ovarian serous adenocarcinoma (HGSOC). COV362 exhibits epithelial-like morphology with polygonal and fusiform cell shape and adherent culture properties. It demonstrates anchorage-independent growth in agar and exhibits prominent structural rearrangements in chromosomes 1, 3, 7, and 11. COV362 carrying TP53 and BRCA1 gene mutation. It is tumorigenic in a nude mouse model but is normally considered as either subcutaneous or intraperitoneal xenografts.
View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • The COV362 cell line finds diverse applications, serving as a valuable tool in the creation of xenograft models for preclinical drug development insights, exploring the impact of estrogen supplementation on ovarian cancer behavior and targeted therapeutic responses. Additionally, it proves crucial in genomic analyses, reflecting the prevalent high-grade serous ovarian cancer (HGSOC) subtype. Moreover, COV362 serves as a robust model for testing potential therapies, including innovative approaches like CAR-T cell therapies.

Inquiring COV362

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button